Evidence map›Paper›PMID 37287041›Full record

ArticleImplementation science communications2023

Interactive assistance via eHealth for small- and medium-sized enterprises' employer and health care manager teams on tobacco control (eSMART-TC): protocol for a cluster randomized hybrid type II trial (N-EQUITY2101/J-SUPPORT2102).

Junko Saito, Miyuki Odawara, Maiko Fujimori, Aya Kuchiba, Shunsuke Oyamada, Khin Thet Swe, Eiko Saito, Kota Fukai, Masayuki Tatemichi, Masakazu Nakamura and 2 more

Open access · goldAbstract read
In one paragraph

Article in Implementation science communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Junko SaitoDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Miyuki OdawaraDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Maiko FujimoriDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Aya KuchibaDivision of Biostatistical Research, Institute for Cancer Control/Biostatistics Division, CRAS, National Cancer Center, Tokyo, Japan.
Shunsuke OyamadaDepartment of Biostatistics, JORTC Data Center, Tokyo, Japan.
Khin Thet SweResearch Center for Health Policy and Economics, Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan.
Eiko SaitoInstitute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Kota FukaiDepartment of Preventive Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Masayuki TatemichiDepartment of Preventive Medicine, Tokai University School of Medicine, Kanagawa, Japan.
Masakazu NakamuraHealth Promotion Research Center, Institute of Community Medicine, Japan Association for Development of Community Medicine, Tokyo, Japan.
Yosuke UchitomiDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Taichi ShimazuDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan. tshimazu@ncc.go.jp.ORCID http://orcid.org/0000-0001-6000-9830
National Cancer Center Hospital East · JPTokai University · JPHitotsubashi University · JPJapan Association for Development of Community Medicine · JPKanagawa University of Human Services · JPNational Cancer Center · USNational Center for Global Health and Medicine · JPResearch Organization of Information and Systems · JP

Funding

Japan Society for the Promotion of Science 21K17319Japan Society for the Promotion of Science 22H03326
6 · The paper itself

Abstract

backgroundTobacco control should be a higher public health priority in Japan. Some workplaces provide smoking cessation support and connect employees to effective smoking cessation treatments such as outpatient clinics. However, tobacco control measures have not been sufficiently implemented in Japan, especially in small- and medium-sized enterprises (SMEs), where resources are limited. Organizational commitment and consistent leadership are crucial to facilitate implementation, but research on whether supporting organizational leaders leads to health behavior changes among employees is limited.

methodsThis hybrid type II cluster randomized effectiveness implementation trial (eSMART-TC) aims to examine the effects of interactive assistance for SME management on health and implementation outcomes. We will provide interactive assistance to employers and health managers for 6 months, aiming to promote the utilization of reimbursed smoking cessation treatments by public health insurance and to implement smoke-free workplaces. The intervention will consist of three strategies: supporting employees through campaigns, tailored ongoing facilitation, and ensuring executive engagement and support. The primary health and implementation outcomes will be salivary cotinine-validated 7-day point-prevalence abstinence rate, and the adoption of two recommended measures (promoting utilization of smoking cessation treatment and implementing smoke-free workplaces) 6 months after the initial session, respectively. Other outcomes for implementation (e.g., penetration of smoking cessation clinic visits), health (e.g., salivary cotinine-validated 7-day point-prevalence abstinence rate at 12 months), and process (e.g., adherence and potential moderating factors) will be collected via questionnaires, interviews, logbooks, and interventionists' notes at 6 and 12 months. An economic analysis will be undertaken to assess the cost-effectiveness of the implementation interventions at 12 months. DISCUSSION: This will be the first cluster randomized controlled trial to evaluate the effectiveness of an implementation intervention with interactive assistance for employers and health managers in SMEs on smoking cessation and implementation of evidence-based tobacco control measures in SMEs. The findings of this trial targeting management in SMEs have the potential to accelerate the implementation of evidence-based smoking cessation methods as well as abstinence rates among employees in SMEs across Japan.

trial registrationThe study protocol has been registered in the UMIN Clinical Trials Registry (UMIN-CTR; ID: UMIN000044526). Registered on 06/14/2021.

Indexed as

EmployerHealth managerImplementationSmall- and medium-sized enterprisesSmoking cessationWorkplace health promotion

Identifiers

PMID37287041
PMCPMC10249242
OpenAlexW4379646252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.